Skip to content

Validation of the Mutuality Scale in Patients With OSA and Their Partners

Psychometric Validation of the Mutuality Scale in Patients With Obstructive Sleep Apnea and Their Partners

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05817123
Acronym
VAMOS
Enrollment
50
Registered
2023-04-18
Start date
2021-05-10
Completion date
2022-09-30
Last updated
2024-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obstructive Sleep Apnea

Brief summary

Main objective of this study is to assess the psychometric characteristics of the Mutuality Scale both in patients with Obstructive Sleep Apnea Syndrome (OSAS) and in their partners-The association between the mutuality score in OSAS patients and their adherence to the use of Continuous Positive Airway Pressure (CPAP) therapy will also be investigated. The results of the study may allow a validation of the Mutuality Score as an instrument for measuring mutuality between OSAS patients and their partners.

Interventions

OTHERQuestionnaires

Administration of the following questionnaires: * Mutuality scale * Pittsburgh Sleep Quality Index (PSQI) * Epworth Sleep Scale (ESS) * Sleep Condition Indicator (SCI) * International Physical Activity Questionaire (IPAQ) * Mediterranean diet score (MDS) * Quality of Life SF 12 * Hospital Anxiety and Depression Scale (HADS)

Sponsors

Istituto Auxologico Italiano
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

OSA patients: Inclusion Criteria: * Age 18 years and older

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Score on Mutuality Scale in OSAS patientsAt baseline15-item scale; points for every item 0-4; minimum score 0; maximum score 60
Score on Mutuality Scale in partnersAt baseline15-item scale; points for every item 0-4; minimum score 0; maximum score 60

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026